This is the first time that a bronchoalveolar lavage (BAL) neutrophil-to-lymphocyte ratio (NL-ratio) has been demonstrated in sarcoidosis and chronic Hypersensitivity Pneumonitis (cHP) than in idiopathic pulmonary fibrosis (IPF) patients.

D'Alessandro, M., Bergantini, L., Carleo, A., Cameli, P., Perrone, A., Fossi, A., et al. (2022). Neutrophil-to-lymphocyte ratio in bronchoalveolar lavage from IPF patients: a novel prognostic biomarker?. MINERVA MEDICA, 113(3), 526-531 [10.23736/S0026-4806.20.06614-8].

Neutrophil-to-lymphocyte ratio in bronchoalveolar lavage from IPF patients: a novel prognostic biomarker?

D'alessandro, Miriana;Bergantini, Laura;Cameli, Paolo;Bargagli, Elena
2022-01-01

Abstract

This is the first time that a bronchoalveolar lavage (BAL) neutrophil-to-lymphocyte ratio (NL-ratio) has been demonstrated in sarcoidosis and chronic Hypersensitivity Pneumonitis (cHP) than in idiopathic pulmonary fibrosis (IPF) patients.
2022
D'Alessandro, M., Bergantini, L., Carleo, A., Cameli, P., Perrone, A., Fossi, A., et al. (2022). Neutrophil-to-lymphocyte ratio in bronchoalveolar lavage from IPF patients: a novel prognostic biomarker?. MINERVA MEDICA, 113(3), 526-531 [10.23736/S0026-4806.20.06614-8].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1110329